
The FDA has approved a new blood-based test for colorectal cancer screening, providing a non-invasive option, but with limitations in detecting precancerous lesions compared to colonoscopy.


coremsg

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, experts said.

A CRC Blood Test Is Here. What Does It Mean for Screening?

fda-approves-new-blood-based-colorectal-cancer-screening-test-potential-benefits-and-limitations


FDA Approves New Blood-Based Colorectal Cancer Screening Test: Potential Benefits and Limitations
